Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

MI-CARE is an innovative coordinated care team intervention to improve medication adherence and blood pressure derived from research findings that build on existing clinical practice. Designed with an eye toward sustainability, MI-CARE incorporates billable pharmacist and CHW services for patients with low medication adherence and high burdens of chronic illness and preventable consequences. MI-CARE offers interprofessional team care with comprehensive expertise and complementary skill sets that mitigate the silo effect of specialized medicine to deliver primary care to diverse, high-risk populations experiencing disparities in hypertension.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• age ≥ 18 years;

• self-report cultural identity as African-American, or Latino;

• speak English, or Spanish;

• have medication-treated hypertension;

• use ≥5 chronic medications;

• have hypertension medication adherence \<85%; and

• able to provide informed consent.

Locations
United States
Massachusetts
Caring Health Center, Inc.
RECRUITING
Springfield
Contact Information
Primary
Vrinda Prakash, MPH
vprakash@caringhealth.org
413-739-1100
Backup
Susan J Shaw, PhD
sjshaw@umass.edu
413-545-7436
Time Frame
Start Date: 2023-08-30
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 230
Treatments
Experimental: MI-CARE Intervention
Pharmacist-community health worker team providing coordinated care tailored to high-risk patients with hypertension. MI-CARE intervention participants will meet with the pharmacist-CHW team for medication optimization and tailored case management. Pill counts will be completed to assess adherence and BP will be measured at each visit to guide antihypertensive medication optimization and provide feedback to participants about their adherence and BP control. Intervention visits will be followed by a booster one month later.
No_intervention: Waitlist Control
Participants enrolled in this arm will receive usual medical care
Related Therapeutic Areas
Sponsors
Collaborators: University of Massachusetts, Amherst
Leads: University of Arizona

This content was sourced from clinicaltrials.gov